إعلان
إعلان
INKT
MiNK Therapeutics, Inc. Common Stock
12.35
USDبرعاية
-0.27
-2.14%
٠٨ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
12.35
0.00
+0.04%
تقارير أرباح INKT
النسبة الإيجابية المفاجئة
INKT تفوق 10 من 17 آخر التقديرات.
59%
التقرير التالي
بيانات التقرير القادم
١٦ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.83
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/+27.69%
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/+33.87%
MiNK Therapeutics, Inc. Common Stock earnings per share and revenue
On ١٤ نوفمبر ٢٠٢٥, INKT reported earnings of -0.65 USD per share (EPS) for Q3 25, beating the estimate of -0.87 USD, resulting in a 25.47% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -3.56% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 المحللين forecast an EPS of -0.83 USD, with revenue projected to reach -- USD, implying an زيادة of 27.69% EPS, and زيادة of 0.00% in Revenue from the last quarter.
الأسئلة الشائعة
What were MiNK Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, MiNK Therapeutics, Inc. Common Stock reported EPS of -$0.65, beating estimates by 25.47%, and revenue of $0.00, 0% as expectations.
How did the market react to MiNK Therapeutics, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -3.56%, changed from $13.22 before the earnings release to $12.75 the day after.
When is MiNK Therapeutics, Inc. Common Stock expected to report next?
The next earning report is scheduled for ١٦ مارس ٢٠٢٦.
What are the forecasts for MiNK Therapeutics, Inc. Common Stock's next earnings report?
Based on 4
المحللين, MiNK Therapeutics, Inc. Common Stock is expected to report EPS of -$0.83 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان